Medpace Holdings, Inc. to Report Second Quarter 2021 Financial Results on July 26, 2021
Get Alerts MEDP Hot Sheet
Join SI Premium – FREE
CINCINNATI--(BUSINESS WIRE)-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2021 financial results after the market close on Monday, July 26, 2021. The Company will host a conference call the following morning, Tuesday, July 27, 2021, at 9:00 a.m. ET to discuss these results.
To participate in the conference call, dial 800-219-7113 (domestic) or 574-990-1030 (international) using the passcode 4092073.
To access the conference call via webcast, visit the “Investors” section of Medpace’s website at investor.medpace.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.
A supplemental slide presentation will also be available at the “Investors” section of Medpace’s website prior to the start of the call.
A recording of the call will be available until Tuesday, August 3, 2021. To hear this recording, dial 855-859-2056 (domestic) or 404-537-3406 (international) using the passcode 4092073.
About Medpace
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 3,900 people across 40 countries as of March 31, 2021.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210527005764/en/
Investor Contact:
Lauren Morris
513.579.9911 x11994
[email protected]
Media Contact:
Julie Hopkins
513.579.9911 x12627
[email protected]
Source: Medpace Holdings, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Upgrades Medpace (MEDP) to Buy, 'Big Margin Improvements'
- RootPath Announces Publication Demonstrating How Its Novel Gene Synthesis Technology Empowers Cell Therapy in Solid Tumor Cancers
- The Coca-Cola Company and Microsoft announce five-year strategic partnership to accelerate cloud and generative AI initiatives
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!